All In Biotech

Drug Trial Radar · NCT00650455

Efficacy and Safety of Valdecoxib and Naproxen in Treating the Signs and Symptoms of Rheumatoid Arthritis (RA) in a Severe Rheumatoid Arthritis Patients

Clinical Protocol for a Multicenter, Double-Blind, Randomized, Placebo Controlled, Comparison of the Efficacy and Safety of Bextra® (Valdecoxib) 10 mg Once Daily and Naproxen 500 mg Twice Daily in Treating the Signs and Symptoms of Rheumatoid Arthritis (RA) in a Severe RA Population

Last checked: Nov 20, 2026Latest source record: Jul 21, 2008 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

489

Actual

Start

Feb 2003

Primary completion

Jan 2005

Study completion Jan 2005

Sponsor

Lead sponsor
PfizerPfizer (PFE)
Sponsor type
Industry
First posted
Apr 1, 2008

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The objectives of the study were to evaluate the efficacy, safety, and tolerability of valdecoxib 10 mg once daily (QD) or naproxen 500 mg twice daily (BID) versus placebo, and to assess the efficacy of valdecoxib 10 mg QD versus naproxen 500 mg BID, in treating the signs and symptoms of rheumatoid arthritis (RA) in a severe Rheumatoid Arthritis population.

Conditions

  • Arthritis, Rheumatoid

Interventions

  • valdecoxibDrug

    valdecoxib 10 mg tablet once daily for 12 weeks

  • naproxenDrug

    naproxen 500 mg capsule twice daily for 12 weeks

  • placeboDrug

    placebo tablet every morning and capsule every evening for 12 weeks

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. ACR-20 criteria responderTime frame: Week 12

Locations

55 sites in 2 countries. Site status is shown where the registry gives one.

  • Pfizer Investigational Site

    Birmingham, Alabama

  • Pfizer Investigational Site

    Huntsville, Alabama

  • Pfizer Investigational Site

    Glendale, Arizona

  • Pfizer Investigational Site

    Glendale, Arizona

  • Pfizer Investigational Site

    Mesa, Arizona

  • Pfizer Investigational Site

    Paradise Valley, Arizona

  • Pfizer Investigational Site

    Phoenix, Arizona

  • Pfizer Investigational Site

    Scottsdale, Arizona

  • Pfizer Investigational Site

    Tucson, Arizona

  • Pfizer Investigational Site

    Fullerton, California

  • Pfizer Investigational Site

    Rancho Mirage, California

  • Pfizer Investigational Site

    San Diego, California

  • Pfizer Investigational Site

    Fort Lauderdale, Florida

  • Pfizer Investigational Site

    Jacksonville, Florida

  • Pfizer Investigational Site

    Jupiter, Florida

  • Pfizer Investigational Site

    Ocala, Florida

  • Pfizer Investigational Site

    Orlando, Florida

  • Pfizer Investigational Site

    Palm Harbor, Florida

  • Pfizer Investigational Site

    Tampa, Florida

  • Pfizer Investigational Site

    West Palm Beach, Florida

  • Pfizer Investigational Site

    Zephyrhills, Florida

  • Pfizer Investigational Site

    Idaho Falls, Idaho

  • Pfizer Investigational Site

    Chicago, Illinois

  • Pfizer Investigational Site

    Springfield, Illinois

  • Pfizer Investigational Site

    Indianapolis, Indiana

  • Pfizer Investigational Site

    Frederick, Maryland

  • Pfizer Investigational Site

    Greenbelt, Maryland

  • Pfizer Investigational Site

    Lansing, Michigan

  • Pfizer Investigational Site

    Jackson, Mississippi

  • Pfizer Investigational Site

    Marlton, New Jersey

  • Pfizer Investigational Site

    Passaic, New Jersey

  • Pfizer Investigational Site

    Teaneck, New Jersey

  • Pfizer Investigational Site

    Brooklyn, New York

  • Pfizer Investigational Site

    New York, New York

  • Pfizer Investigational Site

    New York, New York

  • Pfizer Investigational Site

    Columbus, Ohio

  • Pfizer Investigational Site

    Allentown, Pennsylvania

  • Pfizer Investigational Site

    Duncansville, Pennsylvania

  • Pfizer Investigational Site

    Erie, Pennsylvania

  • Pfizer Investigational Site

    Johnstown, Pennsylvania

Showing 40 of 55 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.